30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Healthcare Sector Insider Trading Activity

Verfolgen Sie Insider-Käufe und -Verkäufe bei Healthcare-Aktien. Sehen Sie, welche Führungskräfte kaufen, die Netto-Inside-Aktivität und % des gehandelten Free Floats über 3,186 Unternehmen.
Die in diesem Screen bereitgestellten Informationen dienen nur zu Informationszwecken und stellen keine Finanzberatung dar. Wir befürworten keine spezifische Investition basierend auf diesen Kriterien.
Unternehmen
Daten
Abonnieren, um auf vollständige Daten zuzugreifen
Unternehmen Geschäftsfeld Marktkapitalisierung ($) # Insidern mit Nettokäufen Nettowert gekauft ($) % des Streubesitzes gekauft % der von Insidern gehaltenen Aktien
Pharmaceuticals & Medical Research Small (1.9bn) 1–5 $10M–$100M 0–15% 0–15%
Healthcare Services Small (1.9bn) -1–5 -$100K–$1M -0–15% 0–15%
US Neogen Corp (NEOG)
Healthcare Services Small (1.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.9bn) 1–5 $10M–$100M 0–15% 50%+
Pharmaceuticals & Medical Research Small (1.9bn) 0 Keine Aktivität — 0–15%
SE Elekta AB (publ) (EKTA-B)
Healthcare Services Small (1.9bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Small (1.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.9bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.9bn) 0 Keine Aktivität — 0–15%
SE AddLife AB (ALIF-B)
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
US Novocure Ltd (NVCR)
Healthcare Services Small (1.8bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
SE Vimian Group AB (VIMIAN)
Healthcare Services Small (1.8bn) -1–5 $10M–$100M 0–15% 0–15%
BE Galapagos NV (GLPG)
Pharmaceuticals & Medical Research Small (1.8bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.8bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Small (1.8bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.8bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.8bn) 0 Keine Aktivität — 0–15%
US Luminex Corp (LMNX)
Healthcare Services Small (1.8bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
US Galecto Inc (GLTO)
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
US Novavax Inc (NVAX)
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.7bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$1M–$10M -0–15% 0–15%
US Uniqure NV (QURE)
Pharmaceuticals & Medical Research Small (1.7bn) -6–10 -$1M–$10M -0–15% 0–15%
Healthcare Services Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) -1–5 -$1M–$10M -0–15% 50%+
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.7bn) 0 Keine Aktivität — 0–15%
FR Clariane SE (CLARI)
Healthcare Services Small (1.6bn) 1–5 $1M–$10M 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.6bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Small (1.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.6bn) -1–5 -< $100K -0–15% 0–15%
US Innoviva Inc (INVA)
Pharmaceuticals & Medical Research Small (1.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Small (1.6bn) 0 Keine Aktivität — 50%+
Healthcare Services Small (1.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 1–5 $1M–$10M 0–15% 50%+
Healthcare Services Small (1.6bn) 0 Keine Aktivität — 0–15%
US Septerna Inc (SEPN)
Pharmaceuticals & Medical Research Small (1.6bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.6bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.6bn) 0 $10M–$100M 0–15% 0–15%
Healthcare Services Small (1.5bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Small (1.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.5bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) 1–5 < $100K 0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.5bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Small (1.5bn) 0 Keine Aktivität — 0–15%
US Zogenix Inc (ZGNX)
Pharmaceuticals & Medical Research Small (1.5bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.5bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.5bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.4bn) -1–5 -$100K–$1M -0–15% 0–15%
US CareDx Inc (CDNA)
Pharmaceuticals & Medical Research Small (1.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Small (1.4bn) -6–10 -$1M–$10M -0–15% 50%+
FR Medincell SA (MEDCL)
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 15–50%
Healthcare Services Small (1.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.4bn) 0 Keine Aktivität — 0–15%
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 0–15%
US Ardelyx Inc (ARDX)
Pharmaceuticals & Medical Research Small (1.4bn) -6–10 -$100K–$1M -0–15% 0–15%
Healthcare Services Small (1.4bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Small (1.4bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 50%+
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 15–50%
Pharmaceuticals & Medical Research Small (1.4bn) 1–5 $1M–$10M 0–15% 0–15%
US Biohaven Ltd (BHVN)
Pharmaceuticals & Medical Research Small (1.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.4bn) 0 Keine Aktivität — 0–15%
Healthcare Services Small (1.4bn) 0 Keine Aktivität — 50%+
Healthcare Services Small (1.3bn) -1–5 -$10M–$100M -0–15% 0–15%